Sesssion 1: Welcome and Opening
23 September 2026
Opening remarks
Sze Ting
Egyptian Atomic Energy Authority
IAEA Address
Patricia Bautista
WFNMB Address
Savvas Frangos
Award/candle light ceremony
Ajit Padhy memorial lecture
Richard Baum
coffee break
10:30AM - 11:00AM
Session 2: Prostate Cancer 1: The PSMA landscape trials and new compounds in Prostate cancer
23 September 2026
PSMA Across the Prostate Cancer Journey: From Imaging to Treatment Guidance
Jeremie Calais
Radioligand therapy today: efficacy Proven, but at what cost in earlier settings?
Oliver Sartor
Expanding Access to PSMA Theranostics: Are There Affordable Alternatives?
Mike Sathekge
Improving RLT: From Fixed Paradigms to Smarter Strategies
Aviral Singh
Panel Discussion
Lunch break
1:00PM - 2:00PM
Sesssion 3: Next-generation rlt: can new isotopes redefine the treatment paradigm?
23 September 2026
Precision Theranostics with Tb-161: From Prostate to Pan-cancer
Swagat Dash
From Access to Outcomes: The Real-World KwaZulu-Natal Experience with Ac-225 PSMA
Mariza Vorster
225Ac monotherapy vs. 177Lu/225Ac tandem PSMA-RLT
Fadi Khreish
Astatine-211: A New Direction in PSMA-Targeted Alpha Therapy
Tadashi Watabe
Multidisciplinary Tumor Board: Case discussions
Coffee break
3:30PM - 04:00PM
Session 4: Navigating Global Challenges: Country-Specific Bottlenecks and Solutions
23 September 2026
Latest on-the-ground advancements in theranostics practice:
John Koutsikos
Batool Albalooshi
Mariela Agolti
Masha Maharaj
Patricia Bautista
Swagat Dash
- Current therapies being performed at their centre
- Reimbursement pathways and access to treatment
- A glimpse inside their facility
- Key clinical highlights, challenges, and lessons learned
- The regulatory landscape shaping their practice